1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Diabetes and other endocrinal, nutritional and metabolic conditions
  5. Diabetes

Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema after an inadequate response to prior therapy

Technology appraisal guidance [TA301] Published: 27 November 2013

  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History
  • Overview
  • 1 Guidance
  • 2 The technology
  • 3 The manufacturer's submission
  • 4 Consideration of the evidence
  • 5 Implementation
  • 6 Recommendations for further research
  • 7 Related NICE guidance
  • 8 Review of guidance
  • 9 Appraisal Committee members, guideline representatives and NICE project team
  • 10 Sources of evidence considered by the Committee
  • Changes after publication
  • About this guidance
Download guidance (PDF)

Guidance

  • Next

7 Related NICE guidance

  • Published

7 Related NICE guidance

Details are correct at the time of publication. Further information is available on the NICE website.

Published

  • Aflibercept solution for injection for treating wet age\u2011\related macular degeneration. NICE technology appraisal guidance 294 (2013).

  • Ranibizumab for treating visual impairment caused by macular oedema secondary to retinal vein occlusion. NICE technology appraisal guidance 283 (2013).

  • Ranibizumab for treating diabetic macular oedema (rapid review of technology appraisal guidance 237) . NICE technology appraisal guidance 274 (2013).

  • Dexamethasone intravitreal implant for the treatment of macular oedema secondary to retinal vein occlusion. NICE technology appraisal guidance 229 (2011).

  • Type 2 diabetes: the management of type 2 diabetes. NICE clinical guideline 87 (2009).

  • Ranibizumab and pegaptanib for the treatment of age\u2011\related macular degeneration. NICE technology appraisal guidance 155 (2008).

  • Type 1 diabetes. NICE clinical guideline 15 (2004).

  • National Institute for Health and Care Excellence (NICE)

  • Next